KBC Group
GMED icon

KBC Group’s Globus Medical GMED Stock Holding History

KBC Group’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.36M Buy
73,824
+417
+0.6% +$37.4K 0.02% 425
2025
Q4 		$6.41M Sell
73,407
-558
-0.8% -$42.4K 0.01% 421
2025
Q3 		$4.24M Buy
73,965
+30,197
+69% +$1.74M 0.01% 475
2025
Q2 		$2.58M Sell
43,768
-3,241
-7% -$209K 0.01% 543
2025
Q1 		$3.44M Buy
47,009
+826
+2% +$68.3K 0.01% 514
2024
Q4 		$3.82M Buy
46,183
+678
+1% +$53.5K 0.01% 543
2024
Q3 		$3.25M Buy
45,505
+237
+0.5% +$16.7K 0.01% 528
2024
Q2 		$3.1M Buy
45,268
+84
+0.2% +$5.02K 0.01% 524
2024
Q1 		$2.42M Buy
45,184
+1,909
+4% +$103K 0.01% 566
2023
Q4 		$2.31M Buy
43,275
+3,276
+8% +$160K 0.01% 582
2023
Q3 		$1.99M Buy
39,999
+2,738
+7% +$153K 0.01% 585
2023
Q2 		$2.22M Hold
37,261
– – 0.01% 587
2023
Q1 		$2.11M Buy
37,261
+2,662
+8% +$171K 0.01% 636
2022
Q4 		$2.57M Sell
34,599
-756
-2% -$51.5K 0.01% 560
2022
Q3 		$2.11M Buy
35,355
+22,568
+176% +$1.36M 0.01% 542
2022
Q2 		$718K Buy
+12,787
New +$840K ﹤0.01% 708

Other funds holding GMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

KBC Group's GMED Position: Q1 2026 in Review

KBC Group increased its Globus Medical (GMED) stake by 0.57% in Q1 2026, buying an estimated $37.4K and bringing the position to 73,824 shares worth $6.36M. The position accounts for 0.02% of the portfolio, ranked #425.

KBC Group first reported a position in GMED in Q2 2022 and has held it in 16 quarters since. The position peaked at $6.41M in Q4 2025. 603 funds tracked by Wall St. Rank hold GMED as of Q1 2026.

  • KBC Group held 73,824 shares of Globus Medical worth $6.36M as of Q1 2026.
  • KBC Group bought 417 Globus Medical shares in Q1 2026, an estimated $37.4K.
  • Globus Medical made up 0.02% of KBC Group's portfolio in Q1 2026, its #425 holding.
  • KBC Group first reported a position in Globus Medical in Q2 2022 and has held it in 16 quarters since.
  • KBC Group's Globus Medical position peaked at $6.41M in Q4 2025.
  • 603 funds tracked by Wall St. Rank held Globus Medical as of Q1 2026.

Based on KBC Group's 13F filing for Q1 2026, filed 7 May 2026.